Benzinga | Jul 28, 2020 07:21AM EDT

Exagen Q2 EPS $(0.27) Beats $(0.76) Estimate, Sales $8.95M Beat $4.68M Estimate

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.76) by 64.47 percent. The company reported quarterly sales of $8.95 million which beat the analyst consensus estimate of $4.68 million by 91.20 percent.